Predicate |
Object |
contentType |
Journal Article |
endingPage |
1563 |
issn |
1948-5875 |
issueIdentifier |
10 |
pageRange |
1561-1563 |
publicationName |
ACS Medicinal Chemistry Letters |
startingPage |
1561 |
bibliographicCitation |
Kargbo RB. Selective Cyclin-Dependent Kinase Inhibitors and Their Application in Cancer Therapy. ACS Med. Chem. Lett. 2022 Sep 20;13(10):1561–3. doi: 10.1021/acsmedchemlett.2c00417. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5539-6343 |
date |
2022-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/36267128 https://pubmed.ncbi.nlm.nih.gov/PMC9578029 https://doi.org/10.1021/acsmedchemlett.2c00417 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 https://portal.issn.org/resource/ISSN/1948-5875 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Selective Cyclin-Dependent Kinase Inhibitors and Their Application in Cancer Therapy |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f6e823973728aec8c3075d39388b14dd http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.11.22 |